Chemical Company

The dominant presence in some of the pharma intermediate molecules. ‘Europe plus one’ is taking traction for Chemicals. Multi-year contract with Fermion for one of its patented products. Gained traction in the electrolyte additives business. Gradual pickup in pharma demand after a recent lull. In specialty chemicals, company is expanding on the clientele side.

Germany's Lanxess to buy Chemtura for about $2.12 bn in cash

Lanxess's offer of USD 33.50 for each Chemtura share, represents a premium of about 19 percent to the Philadelphia-based company's close on Friday.

Hope to maintain 15% revenue growth in FY17,18: Vinati

Speaking to CNBC-TV18, Vinati Saraf Mutreja, Executive Director, Vinati Organics said that the company expects a 15 percent revenue growth and a Rs 150-200 crore gain from new products for the next two years.

Atul surges 7% ahead of board meet to mull merger

Atul said the meetings of the audit committee and the board have been convened today to consider the merger of Amal (a sick company registered with the BIFR), an associate company, with the company.